Dare Bioscience Inc (DARE) — Strategic Asset Allocation Index
Dare Bioscience Inc (DARE) has a Strategic Asset Allocation Index of 1.1% as of March 2023. Strategic assets (PP&E of $55.40K plus long-term investments of $-) total $55.40K, measured against net assets of $4.97 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Dare Bioscience Inc net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Dare Bioscience Inc Strategic Asset Allocation Index (2014–2021)
This chart shows how Dare Bioscience Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2014 to 2021. As of March 2023, the index stands at 1.1%, representing strategic assets of $55.40K against net assets of $4.97 Million USD. For live market cap and overall valuation, see DARE company net worth.
Annual Strategic Asset Allocation Index for Dare Bioscience Inc (2014–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Dare Bioscience Inc from 2014 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See DARE book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.6% | $242.71K | $242.71K | $- | $38.75 Million | ▼ -13.8 pp |
| 2019 | 14.4% | $63.53K | $63.53K | $- | $440.83K | ▲ +14.3 pp |
| 2018 | 0.1% | $9.40K | $9.40K | $- | $6.73 Million | ▲ +0.1 pp |
| 2017 | 0.0% | $0.00 | $0.00 | $- | $13.29 Million | ▼ -5.1 pp |
| 2016 | 5.1% | $668.00K | $668.00K | $- | $13.11 Million | ▲ +3.9 pp |
| 2015 | 1.2% | $576.00K | $576.00K | $- | $48.74 Million | ▲ +0.4 pp |
| 2014 | 0.8% | $342.00K | $342.00K | $0.00 | $45.33 Million | — |